Colombia advances in the search for its health sovereignty, thanks to the construction of the VaxThera vaccine plant
The facility is located in the municipality of Rionegro, Antioquia, and will have the capacity to produce more than 100 million doses of biological products annually. Colombia will be one of five countries in Latin America with the capacity to produce its own vaccines and therapies. May 2024 VaxThera, a 100% Colombian biotechnology company, has […]
Colombian Company VaxThera Receives Key Patent Grant for Locally Developed COVID-19 Vaccine
Medellín, julio de 2024. VaxThera, a Colombian biotechnology company focused on developing vaccines and biologics that contribute to the health sovereignty of Colombia and the region, announced that the United States Patent and Trademark Office (USPTO) has granted a patent for its coronavirus vaccine. The patent covers a mosaic protein designed to provide broad protection […]
The Ministry of Health and Social Protection of Colombia and the National Health Institute of Colombia sign an agreement with VaxThera to strengthen health sovereignty
The Special Framework Agreement for Scientific and Technological Cooperation signed between Ministry of Health and Social Protection of Colombia, the National Health Institute of Colombia (INS), and VaxThera represents an innovation model that seeks to join efforts to strengthen local capacities in terms of health sovereignty. Medellín, February 28th, 2025 – As part of the […]
VaxThera Achieves LEED® Gold Certification for Its Manufacturing Facility, Reinforcing Its Commitment to Sustainability
With a design focused on water and energy efficiency, VaxThera has achieved LEED Gold certification, validated by GBCI, marking a milestone that endorses its commitment to environmental performance and the well-being of people.. Medellín, February 2026 — VaxThera, a Colombian biotechnology company located in Rionegro, announces that it has obtained LEED® Gold certification for its […]
VaxThera builds partnerships and infrastructure to export science and technology in vaccines and biologics
June 1, 2023 – VaxThera, a Colombian biotechnology company, has inaugurated its vaccine and biologicals research facility in Medellín. This milestone underscores the company’s commitment to building infrastructure and expertise in research, development, and innovation within the country. “At VaxThera, we have been strengthening our scientific and technological capabilities to position Colombia as a leader […]
VaxThera and Hetero announce strategic alliance to expand access to high-cost biologic therapies
Collaboration begins with three monoclonal antibodies and establishes a pathway toward technology transfer and local production in Colombia for Latin America MEDELLÍN, Colombia. VaxThera S.A.S., a Colombian biotechnology company, and Hetero Biopharma Limited, an Hetero Group Company, a global pharmaceutical company with established expertise in biosimilars, announced a strategic alliance to expand timely and equitable […]
VaxThera and Codagenix Partner to Advance a Next Generation Yellow Fever Vaccine
Medellín, Colombia, and Farmingdale, Nueva York, September 16th 2026. VaxThera S.A.S., a Colombian biotechnology company developing and manufacturing vaccines and advanced biological products (“VaxThera”), and Codagenix Inc., a clinical-stage biotechnology company pioneering synthetic biology-based vaccines (“Codagenix”), today announced an agreement on terms for VaxThera to exclusively license Codagenix’s yellow fever vaccine candidate, Syn17D-YF (CDX-470). Under […]
EIB, European Commission and VaxThera boost Latin America’s vaccine capacity by up to 250 million doses a year
The European Investment Bank (EIB), in partnership with the European Commission, is providing a €15 million venture loan to VaxThera, a Colombian biotechnology company developing, manufacturing and commercialising vaccines and biopharmaceutical products. The deal is being announced in New York on the margins of the 81st session of the United Nations General Assembly. This is […]
VaxThera, GC Biopharma and RIGHT Foundation Advance Influenza Vaccine Technology Transfer in Colombia
The project brings together international funding, proven vaccine expertise and local capabilities to strengthen vaccine manufacturing in Colombia and Latin America. VaxThera S.A.S., GC Biopharma and the Research Investment for Global Health Technology Foundation, known as RIGHT Foundation, announced a collaboration to advance the transfer of influenza vaccine manufacturing technology to Colombia. Supported by funding […]
VaxThera and Seguros SURA Launch Colombia’s Largest Regional Program to Prevent HPV Associated Cancer
Medellín, September 2025. In Colombia, cervical cancer is the leading cause of cancer-related death among women aged 20 to 35, largely driven by Human Papillomavirus (HPV) infection. This alarming reality exists within a regional context in which 16.1% of women in Latin America are living with chronic HPV infection, compared with a global average of […]
